HuGE Literature Finder
Records
1
-
2
A randomized phase II trial of azacitidine +/- epoetin-ß in lower-risk myelodysplastic syndromes resistant to erythropoietic stimulating agents. Haematologica 2016 May . Thépot Sylvain, Ben Abdelali Raouf, Chevret Sylvie, Renneville Aline, Beyne-Rauzy Odile, Prébet Thomas, Park Sophie, Stamatoullas Aspasia, Guerci-Bresler Agnes, Cheze Stéphane, Tertian Gérard, Choufi Bachra, Legros Laurence, Bastié Jean Noel, Delaunay Jacques, Chaury Marie Pierre, Sanhes Laurence, Wattel Eric, Dreyfus Francois, Vey Norbert, Chermat Fatiha, Preudhomme Claude, Fenaux Pierre, Gardin Clau |
The prognostic impact of minimal residual disease in patients with chronic lymphocytic leukemia requiring first-line therapy. Haematologica 2014 May 99 (5): 873-80. Santacruz Rodrigo, Villamor Neus, Aymerich Marta, Martínez-Trillos Alejandra, López Cristina, Navarro Alba, Rozman María, Beà Sílvia, Royo Cristina, Cazorla Maite, Colomer Dolors, Giné Eva, Pinyol Magda, Puente Xose S, López-Otín Carlos, Campo Elías, López-Guillermo Armando, Delgado Jul |
- Page last reviewed:Jul 25, 2022
- Page last updated:Jan 27, 2023
- Content source: